|
USP13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65201186064223E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.69810001802307E-09 |
| Normal-vs-Stage2 |
9.63549999788427E-08 |
| Normal-vs-Stage3 |
2.760400E-03 |
| Normal-vs-Stage4 |
8.176200E-02 |
| Stage1-vs-Stage2 |
8.052400E-01 |
| Stage1-vs-Stage3 |
3.306200E-02 |
| Stage1-vs-Stage4 |
9.906100E-02 |
| Stage2-vs-Stage3 |
7.336100E-02 |
| Stage2-vs-Stage4 |
1.243020E-01 |
| Stage3-vs-Stage4 |
6.334600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.99240623999231E-12 |
| Normal-vs-AfricanAmerican |
2.29759988812361E-10 |
| Normal-vs-Asian |
7.004200E-02 |
| Caucasian-vs-AfricanAmerican |
4.328200E-01 |
| Caucasian-vs-Asian |
2.230600E-01 |
| AfricanAmerican-vs-Asian |
1.341050E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.75670003175344E-09 |
| Normal-vs-Female |
3.005800E-04 |
| Male-vs-Female |
2.3959999999934E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.60740000490989E-08 |
| Normal-vs-Extreme_Weight |
4.82969997328553E-09 |
| Normal-vs-Obese |
8.18590000006836E-07 |
| Normal-vs-Extreme_Obese |
4.12950000000523E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.117000E-01 |
| Normal_Weight-vs-Obese |
2.913000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.975800E-01 |
| Extreme_Weight-vs-Obese |
1.511970E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.706400E-01 |
| Obese-vs-Extreme_Obese |
1.524560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.511600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.99000055217869E-10 |
| Normal-vs-Age(61-80Yrs) |
8.23099999269772E-09 |
| Normal-vs-Age(81-100Yrs) |
5.30160026990245E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.150400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.341570E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.381400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.355960E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.374600E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.143500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.7782000033838E-08 |
| Normal-VS-Type2 PRCC |
6.98970004098243E-09 |
| Normal-VS-KIRP CIMP |
1.094630E-01 |
| Normal-VS-Unclassified PRCC |
1.63353999999005E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.747600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.769300E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.114800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.828000E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.463580E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.65195999999312E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.28609950151338E-10 |
| Normal-vs-N1 |
2.033400E-01 |
| Normal-vs-N2 |
7.676400E-01 |
| N0-vs-N1 |
3.787900E-04 |
| N0-vs-N2 |
1.410970E-01 |
| N1-vs-N2 |
7.439400E-01 |
|
|
